November 2010 newsletter news : No mix up on Mixtard
Regarding the discontinuation of Novo Nordisk’s Mixtard30, only the Mixtard30 InnoLet is being discontinued — the InnoLet device will still be available with two other
Regarding the discontinuation of Novo Nordisk’s Mixtard30, only the Mixtard30 InnoLet is being discontinued — the InnoLet device will still be available with two other
Diabetic Haidee Merritt makes the most of her health by coming up with cartoons that amusingly address aspects of living with the condition. She says,
Ever pulled your pump tubing out? Well, you are not the only one. But thankfully, most people who’ve done something daft with their pump have
A super look at how carbs in our diet have been compromised. Prof Jennie Brand-Miller talks about what’s been achieved and what’s next. ‘Science has
Researchers say that when they artificially induced Type 1 diabetes in mice in a recent study, alpha cells converted into insulin-producing beta cells, according to
Sanofi-Aventis, makers of Lantus, an analog insulin, and Apidra, is looking to become a “healthcare” company, not just a drugmaker. The move takes the group
To mark World Diabetes Day on the 14 November, JDRF is posting a different fact about type 1 each day this month. The facts
Dr Foot has compiled 5 top tips to keep you moving this winter. As always lets start with your shoes Ideally you should purchase some
Victoza (liraglutide) is an injectable medicine for people with type 2 diabetes. Today, as part of its Single Technology Appraisal (STA) the National Institute forHealth
In recent years a new categorization known as Type 1.5 Diabetes, or Latent Autoimmune Diabetes in Adults (LADA), has gained increasing acceptance. The terms are